尊龙时凯

2015/05/22

CHINA FOOD AND DRUG ADMINISTRATION APPROVES ZYTIGA® FOR PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

[Beijing], [22 May 2015] – Xian Janssen Pharmaceutical Ltd.

2015/05/14

“You are not alone, love is always here” World Inflammatory Bowel Disease Day Campaign Launched in Beijing

(May 14th, 2015) Today, ahead of May 19th’s World Inflammatory Bowel Disease Day, the China Society of Inflammatory Bowel Disease (IBD) and Xian Janssen Pharmaceutical, Ltd. teamed up to launch the 20...

2015/01/27

Qingdao government adds Remicade® and Velcade® to expanded reimbursement list

QINGDAO, 19 December 2014 – The Qingdao municipal government today released an expanded reimbursement list for drugs treating major illness. The approved list includes 13 new drugs from 9 leading dome...

2015/01/27

Tsinghua-Janssen Leads Collaboration in Fight Against Respiratory Diseases in China

BEIJING, May 29, 2014 — Janssen Pharmaceutical (Janssen) and Tsinghua University jointly launched the 2014 Tsinghua-Janssen Public Health Day at Tsinghua University in Beijing. Marking the 4th co...